Global Medical Microfluidic Devices Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Medical Microfluidic Devices Market Research Report 2024
Microfluidics devices are tiny chips that perform chemical analyses of extremely small volumes of fluids such as blood. Lab-on-a-chip devices, which often use microfluidics, are providing for earlier, more cost-effective disease detection and many other uses, from monitoring to treatment. The global microfluidics market is driven by the demand for low-volume sample analysis and high-throughput screening methodologies and has been fueled by the introduction of advanced technologies, such as lab-on-chip and the demand for in vitro diagnostics (IVDs).
According to Mr Accuracy reports’s new survey, global Medical Microfluidic Devices market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Microfluidic Devices market research.
Key manufacturers engaged in the Medical Microfluidic Devices industry include Roche, Abbott, Fluidigm Corporation, Johnson & Johnson, Siemens Healthcare, Agilent and Bio-Rad Laboratories, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Medical Microfluidic Devices were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Medical Microfluidic Devices market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Microfluidic Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Roche
Abbott
Fluidigm Corporation
Johnson & Johnson
Siemens Healthcare
Agilent
Bio-Rad Laboratories
Segment by Type
Polymer
Glass
Silicon
Other
In-vitro Diagnostics (IVD)
Pharmaceuticals and Medical Devices
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Medical Microfluidic Devices report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Medical Microfluidic Devices market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Microfluidic Devices market research.
Key manufacturers engaged in the Medical Microfluidic Devices industry include Roche, Abbott, Fluidigm Corporation, Johnson & Johnson, Siemens Healthcare, Agilent and Bio-Rad Laboratories, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Medical Microfluidic Devices were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Medical Microfluidic Devices market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Microfluidic Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
Abbott
Fluidigm Corporation
Johnson & Johnson
Siemens Healthcare
Agilent
Bio-Rad Laboratories
Segment by Type
Polymer
Glass
Silicon
Other
Segment by Application
In-vitro Diagnostics (IVD)
Pharmaceuticals and Medical Devices
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Medical Microfluidic Devices report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source